akebia therapeutics, inc. is a biopharmaceutical company headquartered in cambridge, massachusetts, focused on delivering innovative therapies to patients with kidney disease through hypoxia-inducible factor (hif) biology. akebia’s lead product candidate, 

Akebia Therapeutics, Inc.

Sold all AKBA

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Michael Buswell

Peter Fainitsky

New position in AKBA

Bought 2% more AKBA

Bought 341% more AKBA

Bought <1% more AKBA

Cameron Vance

Bought 1% more AKBA

Bought 27% more AKBA

Arjun Banerjee

Amanvir singh

Sold 50% of AKBA

Adeleon3

Bought 100% more AKBA